Dylan C. Dean
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 5
- CAR-T cell therapy research 3
-
- Sarcoma Diagnosis and Treatment 7
- Co-authors
- Francis John Hornicek (22 shared papers)Zhenfeng Duan (22 shared papers)Huirong Shi (2 shared papers)Pichaya Thanindratarn (9 shared papers)Wenlong Feng (3 shared papers)Scott D. Nelson (6 shared papers)Jinglu Wang (2 shared papers)Shen Shen (3 shared papers)
- Journals
- Journal of Orthopaedic Research® (2 papers)Cancer Letters (2 papers)Gynecologic Oncology (1 paper)Molecular Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesChinaThailand
In The Last Decade
Dylan C. Dean
24 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 278
- Oncology 269
- Pulmonary and Respiratory Medicine 263
- Immunology 171
- Molecular Biology 505
Countries citing papers authored by Dylan C. Dean
This map shows the geographic impact of Dylan C. Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan C. Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan C. Dean more than expected).
Fields of papers citing papers by Dylan C. Dean
This network shows the impact of papers produced by Dylan C. Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan C. Dean. The network helps show where Dylan C. Dean may publish in the future.
Co-authors
The 25 scholars most cited alongside Dylan C. Dean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 230 | |
| 2 | 2019 | 128 | |
| 3 | 2020 | 121 | |
| 4 | 2018 | 105 | |
| 5 | 2020 | 67 | |
| 6 | 2018 | 58 | |
| 7 | 2019 | 56 | |
| 8 | 2019 | 54 | |
| 9 | 2019 | 45 | |
| 10 | 2019 | 39 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 19 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 15 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 10 | |
| 18 | ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage. | 2022 | 5 |
| 19 | 2022 | 5 | |
| 20 | 2016 | 4 |
About Dylan C. Dean
Dylan C. Dean is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Rheumatology and Molecular Biology, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Cancer-related Molecular Pathways (5 papers), Bone Tumor Diagnosis and Treatments (4 papers), CAR-T cell therapy research (3 papers), RNA modifications and cancer (3 papers), Cell death mechanisms and regulation (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (278 citations), Oncology (269 citations), Pulmonary and Respiratory Medicine (263 citations), Immunology (171 citations) and Molecular Biology (505 citations). Dylan C. Dean has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Francis John Hornicek, Zhenfeng Duan, Huirong Shi, Pichaya Thanindratarn, Wenlong Feng, Scott D. Nelson, Jinglu Wang, Shen Shen, Juncheng Cui and Zhiwei Chen. Their work appears in journals such as Journal of Orthopaedic Research®, Cancer Letters, Gynecologic Oncology, Molecular Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.